Page last updated: 2024-11-07

n-nitrosopropranolol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-nitrosopropranolol: structure for (E)-isomer & RN given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID128614
CHEMBL ID143513
MeSH IDM0113649

Synonyms (12)

Synonym
brn 4875981
ccris 4203
n-nitrosopropanolol
n-nitrosopropranolol
2-propanol, 1-((1-methylethyl)nitrosoamino)-3-(1-naphthalenyloxy)-
CHEMBL143513
84418-35-9
n-(2-hydroxy-3-naphthalen-1-yloxypropyl)-n-propan-2-ylnitrous amide
DTXSID301004684
n-{2-hydroxy-3-[(naphthalen-1-yl)oxy]propyl}-n-propan-2-ylnitrous amide
EN300-18585762
1-(naphthalen-1-yloxy)-3-[nitroso(propan-2-yl)amino]propan-2-ol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID191494Toxicity (Ames Salmonella Test) in the presence of rat liver S-9 fraction in TA-100 strain (4*10e6 dilution)1983Journal of medicinal chemistry, Mar, Volume: 26, Issue:3
Derivatives of beta-adrenergic antagonists. N-Nitrosopropranolol and N-hydroxypropranolol and its aldonitrone.
AID184702Mutagenic activity (Ames Salmonella Test) in the presence of rat liver S-9 fraction in TA-100 strain1983Journal of medicinal chemistry, Mar, Volume: 26, Issue:3
Derivatives of beta-adrenergic antagonists. N-Nitrosopropranolol and N-hydroxypropranolol and its aldonitrone.
AID184703Mutagenic activity (Ames Salmonella Test) in the presence of rat liver S-9 fraction in TA-100 strain at a conc. of 1000 ug1983Journal of medicinal chemistry, Mar, Volume: 26, Issue:3
Derivatives of beta-adrenergic antagonists. N-Nitrosopropranolol and N-hydroxypropranolol and its aldonitrone.
AID191495Toxicity (Ames Salmonella Test) in the presence of rat liver S-9 fraction in TA-100 strain (4*10e7 dilution)1983Journal of medicinal chemistry, Mar, Volume: 26, Issue:3
Derivatives of beta-adrenergic antagonists. N-Nitrosopropranolol and N-hydroxypropranolol and its aldonitrone.
AID184705Mutagenic activity (Ames Salmonella Test) in the presence of rat liver S-9 fraction in TA-98 strain1983Journal of medicinal chemistry, Mar, Volume: 26, Issue:3
Derivatives of beta-adrenergic antagonists. N-Nitrosopropranolol and N-hydroxypropranolol and its aldonitrone.
AID184706Mutagenic activity (Ames Salmonella Test) in the presence of rat liver S-9 fraction in TA-98 strain at a conc. of 1000 ug1983Journal of medicinal chemistry, Mar, Volume: 26, Issue:3
Derivatives of beta-adrenergic antagonists. N-Nitrosopropranolol and N-hydroxypropranolol and its aldonitrone.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (60.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.27

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.27 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.39 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.27)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]